Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Tildrakizumab1件: Tildrakizumab (tildrakizumab-asmn)1件: Tildrakizumab (Tildrakizumab, Tildrakizumab, Tildrakizumab-asmn) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 162, 271 💬
2Tildrakizumab 100 mg/ml1件: Tildrakizumab (tildrakizumab-asmn)1件: Tildrakizumab (Tildrakizumab, Tildrakizumab, Tildrakizumab-asmn) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 271 💬
3Tildrakizumab Prefilled Syringe1件: Tildrakizumab (tildrakizumab-asmn)1件: Tildrakizumab (Tildrakizumab, Tildrakizumab, Tildrakizumab-asmn) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 162 💬